The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis

Shunmei Liu, Bruno Ifebi, Fred M. Johnson, Alison Xu, Jacquelin Ho, Yunlei Yang, Gary J. Schwartz, Young‐Hwan Jo, Streamson C. ChuaJournal of Clinical Investigation 2023 · DOI

Abstract

Glucose homeostasis can be improved after bariatric surgery, which alters bile flow and stimulates gut hormone secretion, particularly FGF15/19. FGFR1 expression in AGRP-expressing cells is required for bile acids' ability to improve glucose control. We show that the mouse Agrp gene has 3 promoter/enhancer regions that direct transcription of each of their own AGRP transcripts. One of these Agrp promoters/enhancers, Agrp-B, is regulated by bile acids. We generated an Agrp-B knockin FLP/knockout allele. AGRP-B-expressing cells are found in endocrine cells of the pars tuberalis and coexpress diacylglycerol lipase B - an endocannabinoid biosynthetic enzyme - distinct from pars tuberalis thyrotropes. AGRP-B expression is also found in the folliculostellate cells of the pituitary's anterior lobe. Mice without AGRP-B were protected from glucose intolerance induced by high-fat feeding but not from excess weight gain. Chemogenetic inhibition of AGRP-B cells improved glucose tolerance by enhancing glucose-stimulated insulin secretion. Inhibition of the AGRP-B cells also caused weight loss. The improved glucose tolerance and reduced body weight persisted up to 6 weeks after cessation of the DREADD-mediated inhibition, suggesting the presence of a biological switch for glucose homeostasis that is regulated by long-term stability of food availability.

Introduction

Agouti-related protein (AGRP) is a well-known regulator of hunger, typically associated with neurons in the hypothalamic arcuate nucleus (ARC). These neurons fire during fasting to drive food intake. However, metabolic improvements following bariatric surgery—often occurring before significant weight loss—suggested that gut signals like bile acids might regulate glucose through pathways that the classic hypothalamic "hunger" neurons could not fully explain.

This research identifies a novel population of AGRP-expressing cells in the pituitary gland, regulated by a distinct promoter (AGRP-B). This variant acts as a long-term "biological switch" for glucose homeostasis, responding to gut-derived bile acids rather than short-term energy status.

Methods

The study employed a sophisticated genetic and molecular toolkit:

  • Transcriptional Mapping: Identification of three distinct transcription start sites (TSS) for the mouse Agrp gene, resulting in variants AGRP-A, B, and C.
  • CRISPR/Cas9 Engineering: Creation of a novel Agrp-B-FLP mouse line, serving as both a knockout and a genetic handle for intersectional tools.
  • Intersectional DREADDs: Combining Agrp-B-FLP with Agrp-IRES-Cre to selectively inhibit cells expressing both markers using inhibitory designer receptors (hM4Di).
  • Physiological Monitoring: Measurement of transcript responses to fasting, leptin deficiency, and bile acid treatment using RT-PCR and immunofluorescence.

Results: The Three-Promoter Model and Pituitary AGRP-B

Genomic analysis revealed that the Agrp gene is not a single unit but is controlled by three distinct promoters. While AGRP-A is the classic hypothalamic variant, AGRP-B is expressed in the pituitary gland (pars tuberalis and anterior lobe) and is specifically regulated by bile acids.

Figure 1: Genomic architecture of the Agrp gene and validation of transcript variants. (A) Schematic of the three promoter regions (1C, 1B, 1A) and their respective isoforms. (B) RT-PCR gel electrophoresis confirming the presence of distinct AGRP transcripts.

Key Findings:

  • Bile Acid Regulation: Treatment with the bile acid taurocholate reduced AGRP-B mRNA by ~80%, leaving the hypothalamic AGRP-A variant untouched.
  • Protection from Obesity-Induced Diabetes: Mice lacking the AGRP-B variant were protected from glucose intolerance caused by a high-fat diet (HFD), despite similar weight gain to controls.
  • Restored Insulin Secretion: Chemogenetic inhibition of AGRP-B cells in obese mice significantly improved glucose-stimulated insulin secretion (GSIS).
  • A Persistent Metabolic Switch: Improvements in glucose tolerance and weight loss persisted for six weeks after the cessation of DREADD-mediated inhibition, suggesting a stable reset of the body's metabolic set-point.

Discussion

The discovery of AGRP-B-expressing endocrine and folliculostellate cells in the pituitary shifts the understanding of AGRP from a purely neuronal hunger signal to a broader neuroendocrine regulator. These cells co-express markers like DAGLB, suggesting they may utilize endocannabinoid pathways to influence systemic metabolism.

While the upstream regulatory regions are conserved in humans, current databases do not yet show a distinct AGRP-B transcript, highlighting the need for further investigation into human 3D chromatin architecture. Future studies will also aim to isolate the specific contributions of the pars tuberalis versus the anterior lobe populations to this gut-pituitary-metabolic axis.

Reference: Liu, S. M., et al. (2023). The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis. J Clin Invest. 133(7):e164185. https://doi.org/10.1172/JCI164185

Summary updated

Abstract

Glucose homeostasis can be improved after bariatric surgery, which alters bile flow and stimulates gut hormone secretion, particularly FGF15/19. FGFR1 expression in AGRP-expressing cells is required for bile acids' ability to improve glucose control. We show that the mouse Agrp gene has 3 promoter/enhancer regions that direct transcription of each of their own AGRP transcripts. One of these Agrp promoters/enhancers, Agrp-B, is regulated by bile acids. We generated an Agrp-B knockin FLP/knockout allele. AGRP-B-expressing cells are found in endocrine cells of the pars tuberalis and coexpress diacylglycerol lipase B - an endocannabinoid biosynthetic enzyme - distinct from pars tuberalis thyrotropes. AGRP-B expression is also found in the folliculostellate cells of the pituitary's anterior lobe. Mice without AGRP-B were protected from glucose intolerance induced by high-fat feeding but not from excess weight gain. Chemogenetic inhibition of AGRP-B cells improved glucose tolerance by enhancing glucose-stimulated insulin secretion. Inhibition of the AGRP-B cells also caused weight loss. The improved glucose tolerance and reduced body weight persisted up to 6 weeks after cessation of the DREADD-mediated inhibition, suggesting the presence of a biological switch for glucose homeostasis that is regulated by long-term stability of food availability.
BibTeX
@article{liu2023gut,
  author = {Shunmei Liu and Bruno Ifebi and Fred M. Johnson and Alison Xu and Jacquelin Ho and Yunlei Yang and Gary J. Schwartz and Young‐Hwan Jo and Streamson C. Chua},
  title = {{The gut signals to AGRP-expressing cells of the pituitary to control glucose homeostasis}},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci164185},
}
Figure